相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis
Jessica Freundt-Revilla et al.
PLOS ONE (2018)
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential
Earle R. Nestmann
FOOD SCIENCE & NUTRITION (2017)
Role of cannabis in digestive disorders
Hemant Goyal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
The role of CB1 in intestinal permeability and inflammation
Mustafa A. Karwad et al.
FASEB JOURNAL (2017)
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα
Mustafa A. Karwad et al.
FASEB JOURNAL (2017)
Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome
Olga Bednarska et al.
GASTROENTEROLOGY (2017)
GPR55: a new promising target for metabolism?
Eva Tuduri et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2017)
Localization of the 5-hydroxytryptamine 4 receptor in equine enteric neurons and extrinsic sensory fibers
F. Giancola et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Cannabinoids as gastrointestinal anti-inflammatory drugs
A. Fabisiak et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity
Donovan A. Argueta et al.
PHYSIOLOGY & BEHAVIOR (2017)
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system
Jessica Freundt-Revilla et al.
PLOS ONE (2017)
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano et al.
FRONTIERS IN NEUROSCIENCE (2017)
Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor
F. Guida et al.
SCIENTIFIC REPORTS (2017)
Cannabinoids Regulate the Diameter of Pericyte-Containing Retinal Capillaries in Rats
Yuan Zong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Cannabinoid signaling in health and disease
Yan Lu et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2017)
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome
C. Cremon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Brain cannabinoid receptor 2: expression, function and modulation
De-Jie Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels
Stefania Petrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The role of mast cells in functional GI disorders
Mira M. Wouters et al.
GUT (2016)
Endocannabinoids in the gastrointestinal tract
Yunna Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Endocannabinoids in cerebrovascular regulation
Zoltan Benyo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Quantification of nitrergic neurons in the myenteric plexus of gastric antrum and ileum of healthy and diabetic dogs
F. Giancola et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2016)
Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
Linda Gabrielsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation
Klara Gyires et al.
CURRENT NEUROPHARMACOLOGY (2016)
Mast cells in gastrointestinal disorders
Stephan C. Bischoff
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The Role of the Endocannabinoid System in the Brain-Gut Axis
Keith A. Sharkey et al.
GASTROENTEROLOGY (2016)
Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases
Fernando Ochoa-Cortes et al.
INFLAMMATORY BOWEL DISEASES (2016)
Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells
Julia Naidenow et al.
JOURNAL OF INFLAMMATION-LONDON (2016)
FROM PHYTOCANNABINOIDS TO CANNABINOID RECEPTORS AND ENDOCANNABINOIDS: PLEIOTROPIC PHYSIOLOGICAL AND PATHOLOGICAL ROLES THROUGH COMPLEX PHARMACOLOGY
Alessia Ligresti et al.
PHYSIOLOGICAL REVIEWS (2016)
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
Giovanni Sarnelli et al.
PLOS ONE (2016)
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti et al.
PROGRESS IN LIPID RESEARCH (2016)
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
Gemma Navarro et al.
FRONTIERS IN NEUROSCIENCE (2016)
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
Ping Ke et al.
PLOS ONE (2016)
Endocannabinoids in the Gut
Nicholas V. DiPatrizio
CANNABIS AND CANNABINOID RESEARCH (2016)
Excitatory and inhibitory enteric innervation of horse lower esophageal sphincter
R. Chiocchetti et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2015)
Emerging roles for enteric glia in gastrointestinal disorders
Keith A. Sharkey
JOURNAL OF CLINICAL INVESTIGATION (2015)
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Guy A. Cabral et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages (vol 10, e0126839, 2015)
Mirko Lanuti et al.
PLOS ONE (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor
Lewis Taylor et al.
SCIENTIFIC REPORTS (2015)
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
Francesca Borrelli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels
Raffaele Capasso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Palmitoylethanolamide Regulates Development of Intestinal Radiation Injury in a Mast Cell-Dependent Manner
Junru Wang et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
Giuseppe Esposito et al.
GUT (2014)
Canine gut dendritic cells in the steady state and in inflammatory bowel disease
Johannes Junginger et al.
INNATE IMMUNITY (2014)
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain
Megan J. Dowie et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2014)
Immunohistochemical Expression of Ionized Calcium Binding Adapter Molecule 1 in Cutaneous Histiocytic Proliferative, Neoplastic and Inflammatory Disorders of Dogs and Cats
F. Pierezan et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2014)
Capillary pericytes regulate cerebral blood flow in health and disease
Catherine N. Hall et al.
NATURE (2014)
Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis
J. Sardinha et al.
MEDIATORS OF INFLAMMATION (2014)
What we know and do not know about the cannabinoid receptor 2 (CB2)
Anna Maria Malfitano et al.
SEMINARS IN IMMUNOLOGY (2014)
Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide
Paolo Ambrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
New Insights in Mast Cell Modulation by Palmitoylethanolamide
D. De Filippis et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2013)
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
Stephen D. Skaper et al.
MOLECULAR NEUROBIOLOGY (2013)
3-D imaging, illustration, and quantitation of enteric glial network in transparent human colon mucosa
Y. A. Liu et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice
Kun Li et al.
NEUROPHARMACOLOGY (2013)
Endocannabinoids: A unique opportunity to develop multitarget analgesics
Sabatino Maione et al.
PAIN (2013)
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis
Luca Campora et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2012)
Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice
Rosanna Di Paola et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Duodenal Enteroendocrine I-Cells Contain mRNA Transcripts Encoding Key Endocannabinoid and Fatty Acid Receptors
Alexandros G. Sykaras et al.
PLOS ONE (2012)
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice
Gracious R. Ross et al.
PHARMACOLOGY (2012)
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
Giuseppina Cantarella et al.
BIOCHEMICAL PHARMACOLOGY (2011)
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
X. -H. Lin et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Endocannabinoid signal in the gut controls dietary fat intake
Nicholas V. DiPatrizio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
S100B protein in the gut: The evidence for enteroglial-sustained intestinal inflammation
Carla Cirillo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
GPR55: Current Knowledge and Future Perspectives of a Purported Type-3 Cannabinoid Receptor
A. Moriconi et al.
CURRENT MEDICINAL CHEMISTRY (2010)
PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways
Huoyan Ji et al.
INFLAMMATION RESEARCH (2010)
PPARα contributes to colonic protection in mice with DSS-induced colitis
Yasu-Taka Azuma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
Luciano De Petrocellis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
The endocannabinoid system links gut microbiota to adipogenesis
Giulio G. Muccioli et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Dendritic Cell Regulation by Cannabinoid-Based Drugs
Mattias Svensson et al.
PHARMACEUTICALS (2010)
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting
Nissar A. Darmani
PHARMACEUTICALS (2010)
Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew
Andrew P. Ray et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabricio A. Moreira et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
Lucia Marquez et al.
PLOS ONE (2009)
The therapeutic potential of novel cannabinoid receptors
Faith R. Kreitzer et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
Marnie Duncan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
′Entourage′ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
W-S V. Ho et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
K. L. Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa
Maria Ruth Pazos et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis
Sven Kleinschmidt et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2007)
The endocannabinoid system and gut-brain signalling
Martin A. Storr et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: Potential use in companion animals
G. Re et al.
VETERINARY JOURNAL (2007)
Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1
Dong-Liang Hu et al.
CELLULAR MICROBIOLOGY (2007)
Endocannabinoid overactivity and intestinal inflammation
V. Di Marzo et al.
GUT (2006)
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
JC Ashton et al.
NEUROSCIENCE LETTERS (2006)
Gene ancestry of the cannabinoid receptor family
JK Anday et al.
PHARMACOLOGICAL RESEARCH (2005)
Review article: endocannabinoids and their receptors in the enteric nervous system
M Duncan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
The search for the palmitoylethanolamide receptor
J LoVerme et al.
LIFE SCIENCES (2005)
Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1β-stimulated human astrocytes
WS Sheng et al.
GLIA (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
Prognostic value of intratumoral vessel density in cutaneous mast cell tumours of the dog
R Preziosi et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2004)
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors
SA Golech et al.
MOLECULAR BRAIN RESEARCH (2004)
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon
M Storr et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Activation of peroxisome proliferator-activated receptors α and γ1 inhibits human smooth muscle cell proliferation
P Zahradka et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Presence of hemodynamic elements in the intestinal vascular system
KH Wille et al.
ANATOMIA HISTOLOGIA EMBRYOLOGIA (2003)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus
AA Coutts et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2002)
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB1 and CB2-like receptors
WP Farquhar-Smith et al.
PAIN (2002)
Anandamide receptors
V Di Marzo et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors
L De Petrocellis et al.
FEBS LETTERS (2001)
Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret
MD Van Sickle et al.
GASTROENTEROLOGY (2001)
Isolation and purification of canine adipose microvascular endothelial cells
KN Kader et al.
MICROVASCULAR RESEARCH (2001)
Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system
A Kulkarni-Narla et al.
CELL AND TISSUE RESEARCH (2000)
分享论文
